Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29203952
Publication Date : //

Effect of intra-tumoral magnetic nanoparticle hyperthermia and viral nanoparticle immunogenicity on primary and metastatic cancer.


Although there is long association of medical hyperthermia and immune stimulation, the relative lack of a quantifiable and reproducible effect has limited the utility and advancement of this relationship in preclinical/clinical cancer and non-cancer settings. Recent cancer-based immune findings (immune checkpoint modulators etc.) including improved mechanistic understanding and biological tools now make it possible to modify and exploit the immune system to benefit conventional cancer treatments such as radiation and hyperthermia. Based on the prior experience of our research group including; cancer-based heat therapy, magnetic nanoparticle (mNP) hyperthermia, radiation biology, cancer immunology and Cowpea Mosaic Virus that has been engineered to over express antigenic proteins without RNA or DNA (eCPMV/VLP). This research was designed to determine if and how the intra-tumoral delivery of mNP hyperthermia and VLP can work together to improve local and systemic tumor treatment efficacy. Using the C3H mouse/MTG-B mammary adenocarcinoma cell model and the C57-B6 mouse/B-16-F10 melanoma cancer cell model, our data suggests the appropriate combination of intra-tumoral mNP heat (e.g. 43°C/30-60 minutes) and VLP (100 μg/200 mm tumor) not only result in significant primary tumor regression but the creation a systemic immune reaction that has the potential to retard secondary tumor growth (abscopal effect) and resist tumor rechallenge. Molecular data from these experiments suggest treatment based cell damage and immune signals such as Heat Shock Protein (HSP) 70/90, calreticulin, MTA1 and CD47 are potential targets that can be exploited to enhance the local and systemic (abscopal effect) immune potential of hyperthermia cancer treatment.

Authors : Hoopes P Jack , Mazur Courtney M , Osterberg Bjorn , Song Ailin , Gladstone David J , Steinmetz Nicole F , Veliz Frank A , Bursey Alicea A , Wagner Robert J , Fiering Steven N ,

Related products :

Catalog number Product name Quantity
Z5060001 GoldMag_CS Nanoparticle (50 nm) 1 ml
Z5060001 GoldMag_CS Nanoparticle (50 nm) 1 ml
N_0101_1MG ANANAS poly-avidin nanoparticles (code_ N-0101) in PBST_tween_glycerol. Each nanoparticle is composed of about 350 avidins and its size (by DLS) is about 120 nm. 1,0 mg
N_0101_05MG ANANAS poly-avidin nanoparticles (code_ N-0101) in PBST_tween_glycerol. Each nanoparticle is composed of about 350 avidins and its size (by DLS) is about 120 nm. 0,5 mg
SC00A4NP SC00A4NP, Green fluorescent nanoparticle-labeled human MSCs 500,000 Cells.
Metastasis - MET181 Metastatic cancer tissue array, 18 cases of metastatic cancers from 4 anatomic sites 2.5mm
IM20 Biotinylated Antigen Coated Immunogenicity Kit ;Kit for immunogenicity testing
IM10 Passive Coated Immunogenicity Kit ;Kit for immunogenicity testing
CXM481 Cervical cancer tissue array paired with primary and metastatic tumors, 12 cases, 48 samples (1.5mm) 12 Cases
CXM481 Cervical cancer tissue array paired with primary and metastatic tumors, 24 cases, 48 samples (1.5mm) Species Human Anatomic System Reproductive system 1.5 mm
1240 Breast cancer, matched metastatic carcinoma and cancer adjacent normal breast tissue array, including TNM, clinical stage and pathology grade, 48 cases_ 96 cores,
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores; ihc H&E, IHC anti-Cytokeratin
EIAAB40264 Homo sapiens,Human,Metalloreductase STEAP2,PCANAP1,Prostate cancer-associated protein 1,Protein upregulated in metastatic prostate cancer,PUMPCn,Six-transmembrane epithelial antigen of prostate 2,SixT
MET181-5 Human Metastatic Cancer tissue array 5x (4x5)
MET961-1 Human Metastatic Cancer tissue array 1x (8x12)
MET961-5 Human Metastatic Cancer tissue array 5x (8x12)
MET481 Metastatic cancer tissue array of 48 samples (2mm) 24 Cases
MET961-1 Human Metastatic Cancer tissue array 1x (8x12)
MET181-1 Human Metastatic Cancer tissue array 1x (4x5)
MET181-1 Human Metastatic Cancer tissue array 1x (4x5)
MET181-5 Human Metastatic Cancer tissue array 5x (4x5)
MET961-5 Human Metastatic Cancer tissue array 5x (8x12)
MET1501 Metastatic cancer tissue array of 150 samples, >10 organs (1.1mm) 75 Cases
MET1021 Metastatic cancer tissue array of 102 cases, >10 organs (1.5mm) 102 Cases


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur